← Open Payments lookup

KIRA BELLAMY: Open Payments

NPI 1255085809 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,699 in 303 payments from 17 companies in 2025. Trend: 2023 $2,845 · 2024 $4,709 · 2025 $6,699

Food & beverage: $6,615Education: $84
CompanyPaymentsAmount
ABBVIE INC.64$1,677
Madrigal Pharmaceuticals53$1,027
Janssen Biotech, Inc.38$760
Salix Pharmaceuticals, a division of Bausch Health US, LLC39$744
PFIZER INC.24$556
Takeda Pharmaceuticals U.S.A., Inc.25$523
GENZYME CORPORATION10$374
Ardelyx, Inc.11$256
Phathom Pharmaceuticals, Inc.12$181
Organon LLC5$113

Products named: REZDIFFRA, TREMFYA, XIFAXAN, RINVOQ, SKYRIZI, ENTYVIO, XELJANZ, DUPIXENT.

Industry payments across PA — which companies pay providers there.